Pharmaceuticals based on biotechnology such as vaccines, antibody drugs, human cell therapy products and gene therapy using vectors have been the focus of active research and development.
To commercialize these promising research seeds of biopharmaceuticals, it is necessary to build a specialized team that includes R&D, manufacturing and regulatory affairs at an early stage of development due to its complexity and special nature of the manufacturing process.
The success or failure of development depends largely on a capability of the team. Especially in the field of biopharmaceutical, the team's collaboration with SMEs (Subject Mater Experts), the experts of GMP, manufacturing process development (CMC), Regulatory Affairs, and engineering of facilities and equipment, that participate in the team is crucial to development.
We, Nexredge will contribute to the health of patients by providing optimal development support to each cutomer based on our outstanding expertise and experience in this field, and by bringin research seeds to market more smoothly.
In order to achieve the Sustainable Development Goals (SDGs), we will contribute to the achievement of the following 17 major goals.
Nexredge's hands-on consultation, in which we participate directly in our clients' projects, emphasizes a "monozukuri (manifacturing)" perspective.
This unique feature has enabled our highly specialized team to provide strong support for our clients' projects.
There are as many challenges in the development stage as there are clients, and the answers are constantly changing depending on the environment surrounding the client and regulatory trends. We will continue to contribute to smooth product development by staying close to our clientss and working together with them to find the optimal solution.
Nexredge will provide our highly specialized project support system globally, not only in Japan but also in Asia, the U.S., Europe, and other regions.